CD58 and neoplasm: Another CRISPR loss-of-function and gain-of-function screen in the human ovarian carcinoma cell line OVCAR8 to identify molecules regulating T-cell engager (TCE)-mediated T-cell killing revealed that CD58 loss in tumor cells affects T-cell effector functions, along with TCR signaling induced by TCE treatment161.